|Videos|September 11, 2020

Standard of Care in Patients With Heart Failure

Cardiologists review the current pharmacologic treatment options and evaluate hospitalization rates across use of traditional heart failure medications.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Foot wound | Image credit: Alingga - stock.adobe.com

Feasibility Study Shows High Wound Closure Rates in Chronic Diabetic Ulcers

ByPearl Steinzor

February 5th 2026

Insulin syringe | Image Credit: © ixel-Shot-stock.adobe.com

Express Scripts Avoids Fines but Agrees to Major Structural Overhaul

ByMaggie L. Shaw

February 5th 2026

Older woman interacts with smart speaker technology | Image credit: Vadim Pastuh - stock.adobe.com

Smart Speaker Improves Mental Health, A1C in Older Adults With Diabetes

ByPearl Steinzor

January 23rd 2026

Red heart with stethoscope. eggeeggjiew | Stethoscope Heart_AdobeStock_188239868.jpe.jpg

Suboptimal Cardiovascular Risk Management Found in Mexican Adults With Diabetes

ByPearl Steinzor

January 22nd 2026

Diabetes | Image credit: Minerva Studio - stock.adobe.com.jpg

SGLT2 Inhibitors Linked to Lower Risk of CKD, AKI Than GLP-1 RAs

ByPearl Steinzor

January 21st 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Standard of Care in Patients With Heart Failure

Newsletter

Related Content

Feasibility Study Shows High Wound Closure Rates in Chronic Diabetic Ulcers

Express Scripts Avoids Fines but Agrees to Major Structural Overhaul

Smart Speaker Improves Mental Health, A1C in Older Adults With Diabetes

Suboptimal Cardiovascular Risk Management Found in Mexican Adults With Diabetes

SGLT2 Inhibitors Linked to Lower Risk of CKD, AKI Than GLP-1 RAs

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD